Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Interv Cardiol Rep. 1999 Sep;1(3):253-262.

Update on Heparin Anticoagulation During Coronary Intervention.

Author information

1
Cardiology Division, New Mexico Heart Institute, 1001 Coal Road, SE, Albuquerque, NM 87106, USA.

Abstract

Although the equipment, techniques, and adjunctive pharmacologic agents used during coronary angioplasty have evolved dramatically over the past 20 years, unfractionated heparin remains a standard component of the procedure. This article reviews recent data and current concepts regarding the use, importance, and proper dosing of heparin during percutaneous coronary intervention, especially when concomitant platelet glycoprotein IIb/IIIa receptor antagonist therapy is used.

PMID:
11096632
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center